Plumbline Life Sciences, Inc. concluded an agreement to acquire animal health assets of VGX Animal Health, Inc. on May 27, 2014. Under the terms of agreement, consideration includes $2 million in cash in multiple payments, 20% of the outstanding shares of Plumbline Life Sciences. The animal health assets being transferred includes exclusive license with Inovio for animal applications of its growth hormone-releasing hormone (GHRH) technology and animal DNA vaccines plus a non-exclusive license to Inovio electroporation delivery systems.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,180 KRW | +0.32% | +0.32% | +2.32% |
1st Jan change | Capi. | |
---|---|---|
+2.32% | 12.61M | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B | |
-17.66% | 7.32B |
- Stock Market
- Equities
- A222670 Stock
- News Plumbline Life Sciences, Inc.
- Plumbline Life Sciences, Inc. concluded an agreement to acquire animal health assets of VGX Animal Health, Inc.